Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Vaxart's Norovirus [strains Norwalk GI.1 + Sydney GII.4] (bivalent) vaccine?
Norovirus [strains Norwalk GI.1 + Sydney GII.4] (bivalent) vaccine is a recombinant vector vaccine commercialized by Vaxart, with a leading...